Sigh, very disappointed with markets response to this one after such a positive build up.But my disappointment is being offset with CDUs performance this morning - all comes to those who are patient.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%